Purpose <p>In 2021, the U.S. Preventive Services Task Force lowered the recommended start age for colorectal cancer (CRC) screening to 45&#xa0;years. In this study, we examined sociodemographic and health-related factors associated with U.S. adults being told about different CRC screening tests by health professionals.</p> Methods <p>We conducted a cross-sectional, secondary analysis of the 2022 Health Information National Trends Survey. The main outcome was, “Has a doctor or other health professional ever told you there are a few different tests to detect colorectal cancer?” We compared “yes” responses (<i>n</i> = 1945) to “no” or “never” discussed responses combined (<i>n</i> = 878).</p> Results <p>In the multivariable logistic regression model, adults aged 45–49&#xa0;years and females had lower odds of being told about CRC screening tests compared to adults aged 50–75&#xa0;years and males, respectively. Conversely, participants in excellent/very good health compared to those in fair/poor health, those with a history of diabetes compared to no diabetes, and those with higher household income ranges compared with 0 to $19,999 had higher odds of being told about CRC screening tests.</p> Conclusion <p>Increasing CRC screening test awareness, particularly among females and adults aged 45 to 49, may strengthen patient-clinician communication and promote earlier CRC detection.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Correlates of patient-centered discussions on colorectal cancer screening: results from the health information national trends survey (HINTS)

  • Aisha T. Langford,
  • Margaret Sena Akpo,
  • Nancy Buderer,
  • Jinping Xu

摘要

Purpose

In 2021, the U.S. Preventive Services Task Force lowered the recommended start age for colorectal cancer (CRC) screening to 45 years. In this study, we examined sociodemographic and health-related factors associated with U.S. adults being told about different CRC screening tests by health professionals.

Methods

We conducted a cross-sectional, secondary analysis of the 2022 Health Information National Trends Survey. The main outcome was, “Has a doctor or other health professional ever told you there are a few different tests to detect colorectal cancer?” We compared “yes” responses (n = 1945) to “no” or “never” discussed responses combined (n = 878).

Results

In the multivariable logistic regression model, adults aged 45–49 years and females had lower odds of being told about CRC screening tests compared to adults aged 50–75 years and males, respectively. Conversely, participants in excellent/very good health compared to those in fair/poor health, those with a history of diabetes compared to no diabetes, and those with higher household income ranges compared with 0 to $19,999 had higher odds of being told about CRC screening tests.

Conclusion

Increasing CRC screening test awareness, particularly among females and adults aged 45 to 49, may strengthen patient-clinician communication and promote earlier CRC detection.